Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Santiago de Compostela (46)

2024

  1. Carbohydrate antigen 125 on epicardial fat and its association with local inflammation and fibrosis-related markers

    Journal of Translational Medicine, Vol. 22, Núm. 1

  2. Combined Sodium-Glucose-Transporters Inhibitors and Glucagon-Like-Peptide Receptor Agonist Compared With Monotherapy Improves Long-Term Survival: A Real-World Registry

    American Journal of Medicine, Vol. 137, Núm. 8, pp. 761-769.e1

  3. Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study

    Diseases, Vol. 12, Núm. 10

  4. Delay in cardiology consultation after primary care physician referrals in heart failure: Clinical implications

    ESC Heart Failure

  5. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

  6. Endocrine activity of dysfunctional adipose tissue: Cardiovascular risk and progression markers

    International Journal of Cardiology

  7. Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation

    Journal of Cardiovascular Translational Research, Vol. 17, Núm. 1, pp. 13-23

  8. Enhancing patient outcomes: Integrating electronic cardiology consultation in primary care for cancer patients

    European Journal of Clinical Investigation, Vol. 54, Núm. 8

  9. Estimated Technological Obsolescence of Computed Tomography Equipment

    Academic Radiology, Vol. 31, Núm. 3, pp. 951-955

  10. High blood pressure and intracerebral haemorrhage: a recognized risk factor with new knowledge

    European journal of preventive cardiology

  11. Impact of a clinician-to-clinician electronic consultation in heart failure patients with previous hospital admissions

    European Heart Journal - Digital Health, Vol. 5, Núm. 1, pp. 9-20

  12. Population-based disease-group analysis of Spanish excess mortality in the early COVID-19 pandemic period

    Open Heart, Vol. 11, Núm. 1

  13. Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  14. Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry

    Revista Espanola de Cardiologia

  15. The CNIC-polypill (acetylsalicylic acid, atorvastatin, and ramipril), an effective and cost-saving secondary prevention strategy compared with other therapeutic options in patients with ischaemic heart disease

    European Heart Journal Open, Vol. 4, Núm. 2